Neurosteroids and neurological disorders
@article{Park2025NeurosteroidsAN,
title={Neurosteroids and neurological disorders},
author={Gi Wan Park and Hayoung Kim and Seong Hyun Won and Nam Hyun Kim and Sheu-Ran Choi},
journal={The Korean Journal of Physiology \& Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology},
year={2025},
volume={29},
pages={157 - 164},
url={https://api.semanticscholar.org/CorpusID:275512718}
}How local synthesis and metabolism of neurosteroids are modulated in the central nervous system are reviewed and described and whether neurosteroids may play a role as a new therapeutic for the treatment of neurological disorders is discussed.
2 Citations
Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms
- 2025
Medicine
This review examines spinal ECS context dependence, uncovering its bidirectional antinociceptive and pronociceptive effects in neuropathic pain and highlighting the spinal cord’s centrality as the principal site for the initiation and maintenance of neuropathic pain.
Neuroprotective Effects and Mechanisms of Alpiniae oxyphyllae Fructus, a Medicinal and Edible Homologous Herb: Research Advances
- 2025
Medicine, Environmental Science
This review systematically summarizes the neuroprotective effects of AOF and delineates its clinical applications, thereby offering valuable reference and guidance for the prevention and treatment of neurological diseases using AOF.
64 References
Neurosteroids: biochemistry and clinical significance
- 2002
Medicine, Chemistry
Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- 2016
Biology, Chemistry
This review summarises recent approaches that target the neuroactive steroid biosynthetic pathway at different levels aiming to promote neurosteroidogenesis, which may be beneficial not only for neurodegenerative diseases, such as Alzheimer's disease and age‐related dementia, but also for neuropsychiatric diseases, including alcohol use disorders.
Neurosteroids and epilepsy
- 2010
Medicine
The overall evidence suggests that neurosteroids may represent a novel therapeutic strategy in epileptic disorders and a future perspective to control epileptogenicity.
Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
- 2019
Medicine
The effects of both endogenously active and exogenously administered neurosteroids on neural networks across the life span of women and men point to a possible underlying pharmacological connectome by which these neuromodulators might act to modulate memory across diverse altered states of mind.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
- 2014
Medicine, Biology
The current knowledge regarding the role of ALLO in the pathogenesis of MS is reviewed, the potential cellular and molecular pathways that might be influenced by ALLo in the context of disease are discussed, and the possibility that ALLO might influence leukocyte biology and associated neuroinflammatory mechanisms independent of its neuroregenerative properties is raised.
Overview of the Molecular Steps in Steroidogenesis of the GABAergic Neurosteroids Allopregnanolone and Pregnanolone
- 2018
Medicine, Biology
The molecular steps involved in the biochemical conversion of cholesterol to allopregnanolone and pregnanolone within steroidogenic cells are detailed and the development of novel therapeutics for the many neuropsychiatric conditions to which dysregulation of these neurosteroids contributes is included.
Neurosteroids: endogenous regulators of the GABAA receptor
- 2005
Medicine, Chemistry
GABAA (γ-aminobutyric acid type A) receptors mediate most of the 'fast' synaptic inhibition in the mammalian brain and are targeted by many clinically important drugs. Certain naturally occurring…